Results 71 to 80 of about 16,624 (211)
New Zealand Journal of Botany, Volume 64, Issue 1, March 2026.SARS‐CoV2 Omicron and its substrains are still a critical global health issue and extremely contagious, even with widespread vaccination efforts. Hospitalizations and mortality rates linked to these variants are still prevalent. Current therapeutic options face challenges, including low effectiveness, suboptimal pharmacokinetics, and drug resistance ...
Frank Eric Tatsing Foka +1 more
wiley +1 more source
Sixth European seminar in virology on virus\u2013host interaction at single cell and organism level [PDF]
, 2018 The 6th European Seminar in Virology (EuSeV) was held in Bertinoro, Italy, 22\u201324 June 2018, and brought together international scientists and young researchers working in the field of Virology.
Pal\uf9, Giorgio +4 more
core +1 more source
Reviews in Medical Virology, Volume 36, Issue 2, March 2026.ABSTRACT Small randomized controlled trials (RCTs) in COVID‐19 meta‐analyses have been associated with more favourable treatment effects and reduced result stability. This study assessed how trial size impacts effect estimates, statistical stability, and risk of bias.
Dong Hyun Kim +11 more
wiley +1 more source
Scientific Reports, 2021 Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of COVID-19 mild and moderate cases.
Hany M. Dabbous +10 more
doaj +1 more source
f‐Block Element‐Based MOF Thin Films: A Platform for Luminescence, Sensing, and Energy Applications
Small, Volume 22, Issue 16, 17 March 2026.f‐Block element–based metal–organic framework (f‐MOF) thin films offer exceptional potential for luminescent, sensing, and energy‐related applications. This review surveys recent progress in their synthesis, characterization, and functional implementation, emphasizing the diversity of available thin‐film fabrication strategies. The convergence of these
Dong‐Hui Chen, Christof Wöll
wiley +1 more source
Scientific Reports, 2022 Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; hydroxychloroquine; standard care (no specific SARS-CoV-2 ...
Manaf AlQahtani +12 more
doaj +1 more source
Health Science Reports, Volume 9, Issue 2, February 2026.ABSTRACT Background and Aims The COVID‐19 pandemic has posed significant challenges for individuals with obstructive pulmonary diseases (OPDs), such as asthma and chronic obstructive pulmonary disease (COPD). Emerging evidence highlights the complex interplay between SARS‐CoV‐2 infection and OPDs, including increased risks of severe disease, long‐term ...
Behnam Dalfardi +6 more
wiley +1 more source
Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein [PDF]
, 2018 We have produced a new Ebola virus pseudotype: E-S-FLU, which can be handled in biosafety level-1/2 containment for laboratory analysis. E-S-FLU is a single cycle influenza virus coated with Ebolavirus glycoprotein, and it encodes enhanced green ...
Annaert, Wim +6 more
core +1 more source
Immunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.ABSTRACT Background Viral‐respiratory infections are the most prevalent illness among humans. A viral infection affecting lower respiratory tract infections (LRTI) is a critical health concern worldwide. The COVID‐19 pandemic has significantly impacted respiratory health, particularly in individuals with asthma.
Mandana Akhavan +2 more
wiley +1 more source
, 2016 The World Health Organisation estimates that approximately one billion people are infected and up to 500 000 people die from influenza each year.1 The greatest burden of illness usually occurs among children, while the highest burden of severe disease ...
Ghebrehewet, Sam +2 more
core +4 more sources